in.boateng
Submits third-party assay reports on material purchased directly. Based in Osijek.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.49%
n=10
Suppliers covered
8
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043292 | Liraglutide | CPC | CPC-2602-G9942 | Nordanalyt | 2026-Q3 | 97.52 | 4.80 | 89.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041489 | CJC-1295 (no DAC) | QSC | QSC-2601-B6118 | Janoshik | 2026-Q2 | 98.92 | 5.20 | 96.3 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041988 | SS-31 (Elamipretide) | AMB | AMB-2512-D5166 | Kestrel | 2026-Q1 | 99.40 | 5.01 | 98.5 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041559 | TB-500 | QSC | QSC-2507-J6496 | Medutest | 2025-Q4 | 99.93 | 5.41 | 100.2 | Buyer-sourced | 0 | PASS |
| AX-2025-019031 | BPC-157 | ASY | ASY-{CAT}-2128 | Janoshik | 2025-Q4 | 99.58 | 4.74 | 105.7 | Buyer-sourced | 0 | PASS |
| AX-2025-020721 | BPC-157 | SGN | SGN-2507-F9360 | Janoshik | 2025-Q3 | 98.82 | 5.14 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019869 | Semaglutide | HJ | HJ-2507-E6156 | Janoshik | 2025-Q3 | 99.58 | 5.42 | 96.7 | Buyer-sourced | 0 | PASS |
| AX-2025-019882 | MK-677 (Ibutamoren mesylate) | HJ | HJ-2501-G5680 | Kestrel | 2025-Q2 | 99.93 | 5.42 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-020409 | CJC-1295 with DAC | MKM | MKM-2409-W4971 | Medutest | 2025-Q1 | 99.10 | 3.19 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2024-004186 | Kisspeptin-10 | WWB | WWB-2311-T3203 | Medutest | 2024-Q2 | 99.93 | 6.68 | — | Buyer-sourced | 0 | PASS |